pharmaceutical · input

2'-Fucosyllactose (2'-FL HMO)

Human milk oligosaccharide produced via engineered microbial fermentation. 2'-FL is the most abundant HMO in human breast milk, functioning as a prebiotic. Abbott first obtained FDA GRAS status (2014) for US infant formula. DSM-Firmenich and BASF (via Glycom, acquired 2020 for $960M) are primary industrial producers.

4

Source countries

5

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on 2'-fucosyllactose (2'-fl hmo) somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
DKDenmark45%
DEGermany25%
CNChina18%
NLNetherlands5%

Who makes it

Supplier companies

5 companies produce 2'-fucosyllactose (2'-fl hmo).

Abbott Nutrition (Abbott Laboratories)

HQ US

Abbott Nutrition (Abbott Park, Illinois; division of Abbott Laboratories NYSE: ABT; FY2023 Abbott total revenue ~$20B; Nutrition segment ~$8B) is the largest US infant formula manufacturer by market share, producing Similac (the #1 US infant formula brand), Similac Pro-Advance, Similac for Supplementation, Similac Alimentum (hypoallergenic — elemental formula for cow's milk protein allergy), Pediasure (pediatric nutritional supplement), and Ensure (adult nutritional supplement). Abbott's Sturgis, Michigan facility — the primary US Similac manufacturing plant — became the center of the 2022 US infant formula shortage crisis. In February 2022, Abbott voluntarily recalled Similac, Alimentum, and EleCare powdered infant formulas produced at Sturgis after FDA inspections found Cronobacter sakazakii contamination linked to four infant hospitalizations and two deaths. Abbott shut the Sturgis plant (which produced approximately 40% of all US powdered infant formula) for approximately 4.5 months (February to late June 2022). The simultaneous shutdown of the dominant US plant for the dominant US brand — in a market where import certification barriers prevent rapid substitution with foreign formula — produced a national infant formula shortage. US stores implemented purchase limits; WIC program (which covers approximately 50% of US infant formula purchases) faced allocation crises. The shortage lasted approximately 6-8 months before supply normalized. Abbott's Sturgis facility resumed production in June 2022 under a consent decree with FDA.

BASF SE (Nutrition & Health)

HQ DE

German chemical company (XETRA: BAS, HQ Ludwigshafen; ~€69B revenue, world's largest chemical company by revenue); Nutrition & Health division produces vitamin A palmitate, vitamin D3 (cholecalciferol), omega-3 fish oils, and specialty nutrition ingredients used in infant formula premix. BASF is the world's largest producer of vitamin A and a major producer of vitamin D3 and E — the core fat-soluble vitamins in infant formula. BASF competes directly with DSM-Firmenich in vitamins, but does not have Fortitech's premix manufacturing capability — BASF sells bulk vitamins to premix manufacturers. BASF's vitamin production traces to the acquisition of Roche's vitamin division in 2003 (Roche had been the global vitamin cartel leader before the 1999 Vitamins price-fixing scandal that resulted in the largest cartel fine in EU history at the time). The current infant formula vitamin supply chain still has roots in the post-cartel market structure.

FrieslandCampina Ingredients (FrieslandCampina)

HQ NL

Dutch dairy cooperative company (HQ Amersfoort, Netherlands; Royal FrieslandCampina N.V.; ~€13B revenue); Ingredients division produces whey protein concentrate and hydrolyzed whey for infant formula, under the Vivinal brand for infant formula whey proteins. FrieslandCampina is owned by roughly 10,000 Dutch dairy farmers — one of the world's largest farmer-owned co-operatives. FrieslandCampina also sells consumer dairy (Chocomel chocolate milk, Friesche Vlag cream) and professional dairy (cream, butter for food service). The same Dutch farmer co-op that makes the chocolate milk that Dutch children drink after school makes the whey protein in Nestlé NAN and Mead Johnson Enfamil infant formulas globally. FrieslandCampina also owns 98Punt6 TV (Dutch food TV channel) and Dutch Farmers' newspaper De Boer.

Novonesis(NSIS.CO)

HQ DK

Formed January 2024 from the merger of Novozymes A/S and Chr. Hansen Holding A/S — the largest merger in Danish industrial history. Novonesis inherited Chr. Hansen's dairy cultures business (mesophilic starter cultures, probiotics, cheese cultures) plus Novozymes' industrial enzymes. The merger consolidated two of the three largest global fermentation companies into one Copenhagen-area entity.

dsm-firmenich AG(DSFIR.AS)

HQ CH

dsm-firmenich AG (Kaiseraugst, Basel-Land, Switzerland; formed by merger of DSM NV Netherlands and Firmenich SA Geneva, completed May 2023; combined revenue ~€12B of which fragrance ~€3-4B) is the world's third-largest fragrance company. Firmenich (private, Geneva; founded 1895 by Philippe Chuit and Martin Naef) was the world's largest private fragrance house and the only major fragrance company to remain independent until the DSM merger. Firmenich's fragrance heritage includes Chanel No. 5 (Firmenich supplies the fragrance compound to Chanel — one of the most carefully guarded commercial relationships in the fragrance industry; the Chanel No. 5 formula is a Firmenich-originated formula from 1921). DSM contributed nutrition, health, and biosciences (vitamins, carotenoids, animal feed enzymes) to the merger. The combined dsm-firmenich operates manufacturing at Geneva (Switzerland), Haverhill (UK), Neuvy-sur-Barangeon (France), and Florham Park (USA). The Firmenich name is retained in the merged entity's fragrance operations branding.